Business Insider North Carolina
SEE OTHER BRANDS

Your business and economy news from North Carolina

Kuehn Law Encourages Investors of ModivCare, Inc. to Contact Law Firm

NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of ModivCare, Inc. (NASDAQ: MODV) breached their fiduciary duties to shareholders.

According to a federal securities lawsuit, Insiders at ModivCare caused the company to misrepresent or fail to disclose that certain contracts used in ModivCare’s non-emergency medical transportation (“NEMT”) segment caused the Company’s free cash flow to deteriorate and that, as a result, (1) contract renegotiations and pricing accommodations negatively impacted the Company’s adjusted EBITDA; (2) the Company had insufficient liquidity; and (3) positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

If you currently own MODV and purchased prior to November 3, 2022 please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law or call (833) 672-0814.  Kuehn Law pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™  

For additional information, please visit Shareholder Derivative Litigation - Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service